139 related articles for article (PubMed ID: 14420398)
1. The clinical effect of norandrostenolone phenylpropionate (durabolin) in metastasizing mammary cancer patients.
MALMIO K; HISI-BRUMMER L; HORTLING H
Ann Med Intern Fenn; 1960; 49():121-29. PubMed ID: 14420398
[No Abstract] [Full Text] [Related]
2. Norandrostenolone phenylpropionate and norandrostenolone decanoate in the treatment of metastasizing mammary carcinoma.
HORTLING H; MALMIO K; HIISI-BRUMMER L
Acta Endocrinol Suppl (Copenh); 1961; (Suppl 63)():132-42. PubMed ID: 14449065
[No Abstract] [Full Text] [Related]
3. [Clinical use of norandrostenolone phenylpropionate].
VAN OS H; DEMEULEMEESTER J
Bull Soc Sci Med Grand Duche Luxemb; 1959 Oct; 96():287-307. PubMed ID: 13841117
[No Abstract] [Full Text] [Related]
4. [Action of norandrostenolone phenylpropionate (N.A.P.P.) in experimental tumorization].
VERNE J; ROTH PC
Bull Assoc Fr Etud Cancer; 1961; 48():535-7. PubMed ID: 13925515
[No Abstract] [Full Text] [Related]
5. Effect of norandrostenolone phenylpropionate on the riboflavin content of blood.
MARKKANEN T
Ann Med Intern Fenn; 1962; 51():125-7. PubMed ID: 14469994
[No Abstract] [Full Text] [Related]
6. [Preliminary clinical trials with the phenylpropionate of norandrostenolone (PPNA) as a protein anabolizing agent].
HUGUENARD P; GODARD H
Therapie; 1959; 14():738-44. PubMed ID: 14403896
[No Abstract] [Full Text] [Related]
7. [Importance of norandrostenolone phenylpropionate in psychiatric therapy].
BOITTELLE G; BOITTELLE-LENTULO C; DUMEZIL C
Ann Med Psychol (Paris); 1962 Feb; 120(1)():389-92. PubMed ID: 13870704
[No Abstract] [Full Text] [Related]
8. [Use of durabolin (19-nor-androstenolone phenylpropionate) in the therapy of progressive muscular dystrophy].
BEKENY G; KRAFT F; LANG S
Orv Hetil; 1960 Feb; 101():229-34. PubMed ID: 13798373
[No Abstract] [Full Text] [Related]
9. [The use of durabolin (19-nor-androstenolone phenylpropionate) in the therapy of progressive muscular dystrophy].
BEKENY G; KRAFT F; LANG S
Nervenarzt; 1960 Mar; 31():118-23. PubMed ID: 13798372
[No Abstract] [Full Text] [Related]
10. Sex hormones and mammary cancer; experience with durabolin.
VAN DER WERFF JT
Br Med J; 1958 Oct; 2(5101):881-3. PubMed ID: 13572933
[No Abstract] [Full Text] [Related]
11. [Effect of norandrosterolone phenylpropionate (durabolin) in growth retardation in children].
BARTA ; CSERE M; NABRADY J
Gyermekgyogyaszat; 1960 Sep; 11():262-8. PubMed ID: 14448494
[No Abstract] [Full Text] [Related]
12. [Favorable influence of 19-norandrostenolone phenylpropionate on the diabetic retinopathy].
VALK LE
Bull Mem Soc Fr Ophtalmol; 1959; 72():596-608. PubMed ID: 13840861
[No Abstract] [Full Text] [Related]
13. [Effect of nor-androstenolone phenylpropionate (Durabolin) on weight increase in atrophic children].
UJSAGHY P
Gyermekgyogyaszat; 1962 Jul; 13():210-8. PubMed ID: 13923627
[No Abstract] [Full Text] [Related]
14. Failure of 19-nor-androstenolone phenylpropionate (durabolin) to prevent the alterations produced by cortisone on the growing bone in rats.
LARON Z; BOSS JH
Endocrinology; 1961 Sep; 69():608-12. PubMed ID: 13759150
[No Abstract] [Full Text] [Related]
15. [Durabolin in bone pathology].
DREYFUS P
Gaz Med Fr; 1961 Nov; 68():2579-81. PubMed ID: 13887846
[No Abstract] [Full Text] [Related]
16. [Effect of testosterone propionate and of norandrostenolone phenylpropionate on pituitary gonadotropin content in adult rats].
PERUZY AD; LUCHETTI L; MARINOSCI A
Folia Endocrinol Mens Incretologia Incretoterapia; 1959 Dec; 12():808-13. PubMed ID: 14432096
[No Abstract] [Full Text] [Related]
17. [FIRST EXPERIMENTS ON THE ACTION OF NORANDROSTENOLONE PHENYLPROPIONATE (NOR TPP) ON BENZOPYRENE TUMORS IN RATS].
SICCARDI A; ZANGARA A
Arch Maragliano Patol Clin; 1963 Oct; 19():571-80. PubMed ID: 14093847
[No Abstract] [Full Text] [Related]
18. [Preventive action of norandrostenolone phenylpropionate (N.A.P.P.) in experimental tumor induction].
VERNE J; ROTH PC
Bull Assoc Fr Etud Cancer; 1963; 50():49-52. PubMed ID: 13996833
[No Abstract] [Full Text] [Related]
19. The haemopoietic effect of nandrolone-phenylpropionate (Durabolin).
BOOIJ J; KUYPERS J
Acta Physiol Pharmacol Neerl; 1962; 11():12-9. PubMed ID: 13871124
[No Abstract] [Full Text] [Related]
20. Nandrolone phenpropionate: a new palliative agent in the management of mammary carcinoma.
SZUJEWSKI HA
Am Pract Dig Treat; 1959 Dec; 10():2157-9. PubMed ID: 13836459
[No Abstract] [Full Text] [Related]
[Next] [New Search]
